QQ客服 官方微博 反馈留言

	Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice
	Liu, Wenjuan; Son, Dong Ok; Lau, Harry K.; Zhou, Yinghui; Prud'homme, Gerald J.; Jin, Tianru; Wang, Qinghua
刊名	FRONTIERS IN PHARMACOLOGY
	2017
卷号	8
关键词	GABA sitagliptin streptozotocin beta cell diabetes
ISSN号	1663-9812
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3612138
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Liu, Wenjuan,Son, Dong Ok,Lau, Harry K.,et al. Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice[J]. FRONTIERS IN PHARMACOLOGY,2017,8.
APA	Liu, Wenjuan.,Son, Dong Ok.,Lau, Harry K..,Zhou, Yinghui.,Prud'homme, Gerald J..,...&Wang, Qinghua.(2017).Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice.FRONTIERS IN PHARMACOLOGY,8.
MLA	Liu, Wenjuan,et al."Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice".FRONTIERS IN PHARMACOLOGY 8(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。